GlassScriptPhysician profile
Dawn Pennebaker
NPI 1447253745
$3,423.19
in general payments reported to CMS, 2019-2025
37 companies · $685 in 2025
The $685 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $293 · 2021: $498 · 2022: $452 · 2023: $489 · 2024: $601 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $405.43 | 2019-2024 | |
| Astellas Pharma US INC | $349.19 | 2022-2025 | Veozah |
| Pfizer INC. | $327.45 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $233.05 | 2022-2024 | |
| Evofem Biosciences, INC. | $194.27 | 2021-2025 | Phexxi, Solosec, Phexx |
| Aspira Women'S Health INC | $169.53 | 2021 | |
| Lupin INC. | $139.89 | 2019-2021 | |
| Amgen INC. | $133.96 | 2019-2022 | |
| Coopersurgical, INC. | $123.25 | 2019-2024 | Endosee |
| Sumitomo Pharma America, INC. | $121.91 | 2024-2025 | Myfembree |
| Daiichi Sankyo INC. | $105.22 | 2019-2022 | |
| Dexcom, INC. | $97.01 | 2025 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $93.83 | 2024-2025 | Novasure, Myosure Tissue Removal Device, Omni Hysteroscope |
| Ethicon US, LLC | $81.45 | 2020-2025 | Enseal, Surgicel Nu-Knit |
| Exeltis, USA INC. | $77.33 | 2024-2025 | Slynd |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $73.78 | 2022-2025 | Nexplanon, Jada System |
| Novo Nordisk INC | $66.35 | 2024-2025 | Wegovy |
| Intuitive Surgical, INC. | $58.17 | 2019 | |
| Avion Pharmaceuticals | $57.34 | 2020-2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $51.69 | 2019-2024 | Gardasil 9, Gardasil |
| Duchesnay USA Incorporated | $50.38 | 2019 | |
| Lilly USA, LLC | $47.70 | 2023-2025 | Zepbound |
| Femselect INC. | $43.46 | 2023 | Enplace |
| Sage Therapeutics, LLC | $41.73 | 2025 | Zurzuvae |
| Minerva Surgical, INC | $33.69 | 2019-2022 | |
| Exact Sciences Corporation | $31.59 | 2023-2025 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $31.56 | 2024 | Pico 14, Renasys Touch, Pico 7 |
| Takeda Pharmaceuticals U.S.A., INC. | $30.18 | 2024 | Trintellix |
| Axonics, INC. | $29.09 | 2020-2022 | |
| Supernus Pharmaceuticals, INC. | $17.63 | 2025 | Qelbree |
| Medicem INC. | $17.04 | 2022 | |
| Amag Pharmaceuticals, INC. | $17.04 | 2019 | |
| Myovant Sciences INC. | $16.60 | 2022 | |
| Acella Pharmaceuticals, LLC | $16.52 | 2025 | NP Thyroid 60 |
| Scynexis, INC. | $13.78 | 2022 | |
| Axsome Therapeutics, INC. | $13.48 | 2025 | Auvelity |
| Therapeuticsmd, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Pennebaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.